Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Caveolin-1 promotes the tumor suppressor properties of oncogene-induced cellular senescence.

Volonte D, Vyas AR, Chen C, Dacic S, Stabile LP, Kurland BF, Abberbock SR, Burns TF, Herman JG, Di YP, Galbiati F.

J Biol Chem. 2018 Feb 2;293(5):1794-1809. doi: 10.1074/jbc.M117.815902. Epub 2017 Dec 15.

2.

Caveolin-1 controls mitochondrial function through regulation of m-AAA mitochondrial protease.

Volonte D, Liu Z, Shiva S, Galbiati F.

Aging (Albany NY). 2016 Oct 4;8(10):2355-2369. doi: 10.18632/aging.101051.

3.

Oxidative stress-induced inhibition of Sirt1 by caveolin-1 promotes p53-dependent premature senescence and stimulates the secretion of interleukin 6 (IL-6).

Volonte D, Zou H, Bartholomew JN, Liu Z, Morel PA, Galbiati F.

J Biol Chem. 2015 Feb 13;290(7):4202-14. doi: 10.1074/jbc.M114.598268. Epub 2014 Dec 15.

4.

Caveolin-1 regulates genomic action of the glucocorticoid receptor in neural stem cells.

Peffer ME, Chandran UR, Luthra S, Volonte D, Galbiati F, Garabedian MJ, Monaghan AP, DeFranco DB.

Mol Cell Biol. 2014 Jul;34(14):2611-23.

5.

Inhibition of nuclear factor-erythroid 2-related factor (Nrf2) by caveolin-1 promotes stress-induced premature senescence.

Volonte D, Liu Z, Musille PM, Stoppani E, Wakabayashi N, Di YP, Lisanti MP, Kensler TW, Galbiati F.

Mol Biol Cell. 2013 Jun;24(12):1852-62. doi: 10.1091/mbc.E12-09-0666. Epub 2013 May 1.

6.

Interaction of caveolin-1 with Ku70 inhibits Bax-mediated apoptosis.

Zou H, Volonte D, Galbiati F.

PLoS One. 2012;7(6):e39379. doi: 10.1371/journal.pone.0039379. Epub 2012 Jun 20. Erratum in: PLoS One. doi: 10.1371/annotation/83804d5a-9c9b-4b9a-9aa3-cb6da8a78fe9.

7.

Caveolin-1, cellular senescence and age-related diseases.

Zou H, Stoppani E, Volonte D, Galbiati F.

Mech Ageing Dev. 2011 Nov-Dec;132(11-12):533-42. doi: 10.1016/j.mad.2011.11.001. Epub 2011 Nov 12. Review.

8.

Nongenomic glucocorticoid receptor action regulates gap junction intercellular communication and neural progenitor cell proliferation.

Samarasinghe RA, Di Maio R, Volonte D, Galbiati F, Lewis M, Romero G, DeFranco DB.

Proc Natl Acad Sci U S A. 2011 Oct 4;108(40):16657-62. doi: 10.1073/pnas.1102821108. Epub 2011 Sep 19.

9.

Polymerase I and transcript release factor (PTRF)/cavin-1 is a novel regulator of stress-induced premature senescence.

Volonte D, Galbiati F.

J Biol Chem. 2011 Aug 19;286(33):28657-61. doi: 10.1074/jbc.C111.235119. Epub 2011 Jun 24.

10.

Caveolin-1, cellular senescence and pulmonary emphysema.

Volonte D, Galbiati F.

Aging (Albany NY). 2009 Aug 10;1(9):831-5.

11.

Inhibition of thioredoxin reductase 1 by caveolin 1 promotes stress-induced premature senescence.

Volonte D, Galbiati F.

EMBO Rep. 2009 Dec;10(12):1334-40. doi: 10.1038/embor.2009.215. Epub 2009 Oct 9.

12.

Caveolin-1 regulates the antagonistic pleiotropic properties of cellular senescence through a novel Mdm2/p53-mediated pathway.

Bartholomew JN, Volonte D, Galbiati F.

Cancer Res. 2009 Apr 1;69(7):2878-86. doi: 10.1158/0008-5472.CAN-08-2857. Epub 2009 Mar 24.

13.

Caveolin-1 expression is required for the development of pulmonary emphysema through activation of the ATM-p53-p21 pathway.

Volonte D, Kahkonen B, Shapiro S, Di Y, Galbiati F.

J Biol Chem. 2009 Feb 27;284(9):5462-6. doi: 10.1074/jbc.C800225200. Epub 2008 Dec 22.

14.

Caveolin-1 and caveolin-3 form heterooligomeric complexes in atrial cardiac myocytes that are required for doxorubicin-induced apoptosis.

Volonte D, McTiernan CF, Drab M, Kasper M, Galbiati F.

Am J Physiol Heart Circ Physiol. 2008 Jan;294(1):H392-401. Epub 2007 Nov 2.

16.

Spatial and temporal regulation of GLUT4 translocation by flotillin-1 and caveolin-3 in skeletal muscle cells.

Fecchi K, Volonte D, Hezel MP, Schmeck K, Galbiati F.

FASEB J. 2006 Apr;20(6):705-7. Epub 2006 Feb 2.

17.

The modulation of caveolin-1 expression controls satellite cell activation during muscle repair.

Volonte D, Liu Y, Galbiati F.

FASEB J. 2005 Feb;19(2):237-9. Epub 2004 Nov 15.

PMID:
15545301
19.

Transgenic overexpression of caveolin-3 in the heart induces a cardiomyopathic phenotype.

Aravamudan B, Volonte D, Ramani R, Gursoy E, Lisanti MP, London B, Galbiati F.

Hum Mol Genet. 2003 Nov 1;12(21):2777-88. Epub 2003 Sep 9. Erratum in: Hum Mol Genet. 2004 Jan 1;13(1):149.

PMID:
12966035
20.

Expression of caveolin-1 induces premature cellular senescence in primary cultures of murine fibroblasts.

Volonte D, Zhang K, Lisanti MP, Galbiati F.

Mol Biol Cell. 2002 Jul;13(7):2502-17.

21.

Impairment of caveolae formation and T-system disorganization in human muscular dystrophy with caveolin-3 deficiency.

Minetti C, Bado M, Broda P, Sotgia F, Bruno C, Galbiati F, Volonte D, Lucania G, Pavan A, Bonilla E, Lisanti MP, Cordone G.

Am J Pathol. 2002 Jan;160(1):265-70.

22.

Caveolin-1 expression negatively regulates cell cycle progression by inducing G(0)/G(1) arrest via a p53/p21(WAF1/Cip1)-dependent mechanism.

Galbiati F, Volonté D, Liu J, Capozza F, Frank PG, Zhu L, Pestell RG, Lisanti MP.

Mol Biol Cell. 2001 Aug;12(8):2229-44.

24.

Influence of caveolin-1 on cellular cholesterol efflux mediated by high-density lipoproteins.

Frank PG, Galbiati F, Volonte D, Razani B, Cohen DE, Marcel YL, Lisanti MP.

Am J Physiol Cell Physiol. 2001 May;280(5):C1204-14.

25.

Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities.

Galbiati F, Engelman JA, Volonte D, Zhang XL, Minetti C, Li M, Hou H Jr, Kneitz B, Edelmann W, Lisanti MP.

J Biol Chem. 2001 Jun 15;276(24):21425-33. Epub 2001 Mar 19.

27.

Constitutive and growth factor-regulated phosphorylation of caveolin-1 occurs at the same site (Tyr-14) in vivo: identification of a c-Src/Cav-1/Grb7 signaling cassette.

Lee H, Volonte D, Galbiati F, Iyengar P, Lublin DM, Bregman DB, Wilson MT, Campos-Gonzalez R, Bouzahzah B, Pestell RG, Scherer PE, Lisanti MP.

Mol Endocrinol. 2000 Nov;14(11):1750-75.

PMID:
11075810
29.

Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype.

Galbiati F, Volonte D, Chu JB, Li M, Fine SW, Fu M, Bermudez J, Pedemonte M, Weidenheim KM, Pestell RG, Minetti C, Lisanti MP.

Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9689-94.

30.

Caveolin-1 expression inhibits Wnt/beta-catenin/Lef-1 signaling by recruiting beta-catenin to caveolae membrane domains.

Galbiati F, Volonte D, Brown AM, Weinstein DE, Ben-Ze'ev A, Pestell RG, Lisanti MP.

J Biol Chem. 2000 Jul 28;275(30):23368-77.

33.

Characterisation of caveolins from cartilage: expression of caveolin-1, -2 and -3 in chondrocytes and in alginate cell culture of the rat tibia.

Schwab W, Galbiati F, Volonte D, Hempel U, Wenzel KW, Funk RH, Lisanti MP, Kasper M.

Histochem Cell Biol. 1999 Jul;112(1):41-9.

PMID:
10461811
37.

Upregulation of caveolin-1 and caveolae organelles in Taxol-resistant A549 cells.

Yang CP, Galbiati F, Volonte D, Horwitz SB, Lisanti MP.

FEBS Lett. 1998 Nov 20;439(3):368-72.

38.

Molecular genetics of the caveolin gene family: implications for human cancers, diabetes, Alzheimer disease, and muscular dystrophy.

Engelman JA, Zhang X, Galbiati F, Volonte D, Sotgia F, Pestell RG, Minetti C, Scherer PE, Okamoto T, Lisanti MP.

Am J Hum Genet. 1998 Dec;63(6):1578-87. Review. No abstract available.

39.

Affinity-purification and characterization of caveolins from the brain: differential expression of caveolin-1, -2, and -3 in brain endothelial and astroglial cell types.

Ikezu T, Ueda H, Trapp BD, Nishiyama K, Sha JF, Volonte D, Galbiati F, Byrd AL, Bassell G, Serizawa H, Lane WS, Lisanti MP, Okamoto T.

Brain Res. 1998 Sep 7;804(2):177-92.

PMID:
9841091
40.

Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade.

Galbiati F, Volonte D, Engelman JA, Watanabe G, Burk R, Pestell RG, Lisanti MP.

EMBO J. 1998 Nov 16;17(22):6633-48.

41.

Crowded little caves: structure and function of caveolae.

Schlegel A, Volonte D, Engelman JA, Galbiati F, Mehta P, Zhang XL, Scherer PE, Lisanti MP.

Cell Signal. 1998 Jul;10(7):457-63. Review.

PMID:
9754713
42.

Mutational analysis of caveolin-induced vesicle formation. Expression of caveolin-1 recruits caveolin-2 to caveolae membranes.

Li S, Galbiati F, Volonte D, Sargiacomo M, Engelman JA, Das K, Scherer PE, Lisanti MP.

FEBS Lett. 1998 Aug 28;434(1-2):127-34.

43.

Expression of caveolin-1 and -2 in differentiating PC12 cells and dorsal root ganglion neurons: caveolin-2 is up-regulated in response to cell injury.

Galbiati F, Volonte D, Gil O, Zanazzi G, Salzer JL, Sargiacomo M, Scherer PE, Engelman JA, Schlegel A, Parenti M, Okamoto T, Lisanti MP.

Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):10257-62.

44.

Identification, sequence and developmental expression of invertebrate flotillins from Drosophila melanogaster.

Galbiati F, Volonte D, Goltz JS, Steele Z, Sen J, Jurcsak J, Stein D, Stevens L, Lisanti MP.

Gene. 1998 Apr 14;210(2):229-37.

PMID:
9573373
45.

Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy.

Minetti C, Sotgia F, Bruno C, Scartezzini P, Broda P, Bado M, Masetti E, Mazzocco M, Egeo A, Donati MA, Volonte D, Galbiati F, Cordone G, Bricarelli FD, Lisanti MP, Zara F.

Nat Genet. 1998 Apr;18(4):365-8.

PMID:
9537420
46.

Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo.

Scherer PE, Lewis RY, Volonte D, Engelman JA, Galbiati F, Couet J, Kohtz DS, van Donselaar E, Peters P, Lisanti MP.

J Biol Chem. 1997 Nov 14;272(46):29337-46.

Supplemental Content

Loading ...
Support Center